doc. MUDr. Daniela Žáčková, Ph.D.
Associate professor, Department of Internal Medicine, Hematology and Oncology
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Phone: | +420 532 23 2838, 3603 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 218
2010
-
Dasatinib in imatinib-resistant or -intolerant CML patients: data from the clinical practice of 6 hematological centers in the Czech Republic
Neoplasma, year: 2010, volume: 57, edition: 4, DOI
-
Detection of an aberrant form of E13A2 BCR-ABL transcript causing failure of molecular diagnostics in patient with chronic myeloid leukemia (CML)
Year: 2010, type: Conference abstract
-
EUROPEAN SUB-REGISTRY OF CHRONIC MYELOID LEUKEMIA (CML) PATIENTS (PTS) IN FAILURE AFTER IMATINIB THERAPY (IFP): RATIONALE, STUDY DESIGN AND CURRENT STATUS. A STUDY FROM THE EUROPEAN LEUKEMIANET (ELN)
Year: 2010, type: Conference abstract
-
Failure of molecular diagnostics in chronic myeloid leukemia - an aberrant form of e13a2 BCR-ABL transcript causing false-negative results by standard PCR.
LEUKEMIA & LYMPHOMA, year: 2010, volume: 51, edition: 3
-
Frekvence mutací v BCR-ABL kinázové doméně u pacientů s chronickou myeloidní leukémií (CML) léčených tyrozinkinázovými inhibitory - zkušenosti IHOK FN Brno
Year: 2010, type: Conference abstract
-
Chronická myeloidní leukemie v éře tyrozinkinázových inhibitorů
Year: 2010, type: Appeared in Conference without Proceedings
-
Imatinib (IMA) plasma concentration (PC) monitoring and its correlation with treatment response in chronic myelogenous leukemia (CML): a single centre experience
Year: 2010, type: Conference abstract
-
Imatinib in the first line chronic myeloid leukemia (CML) treatment. Can we compare the real-life data to clinical trial results?
Year: 2010, type: Conference abstract
-
Imatinib v první linii léčby pacientů s chronickou myeloidní leukemií (CML) v chronické fázi (CP). Můžeme srovnat výsledky z reálné klinikcé praxe s výsledky dosaženými v klinických studiích?
Year: 2010, type: Conference abstract
-
Mechanismy rezistence k imatinibu: laboratorní a klinická rezistence
Year: 2010, type: Appeared in Conference without Proceedings